HSF1 and amyotrophic lateral sclerosis: We have shown that activation of HSF1/HSP70/DNAJB2a pathway results in a dramatic clearance of TDP-43 aggregates and that directly targeting these HSR components is an important therapeutic opportunity for ALS.